Clinical trial
A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in…
NCT00183963 · University of Southern California, Other · Terminated
Key facts
| NCT number | NCT00183963 |
|---|---|
| Title | A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS) |
| Official title | A Pilot Clinical Trial to Evaluate the Biological Activity of Fulvestrant in Breast Ductal Carcinoma in Situ (DCIS) |
| Lead sponsor | University of Southern California, Other |
| Collaborators | AstraZeneca Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Carcinoma |
| Intervention type | Drug |
| Interventions | Tamoxifen, Fulvestrant |
| Enrollment | 4 |
| Start date | Aug 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Sep 16, 2005 |
| Last update posted | May 22, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: